Skip to main content
. 2019 Oct 14;11(10):1561. doi: 10.3390/cancers11101561

Figure 1.

Figure 1

Double-strand break (DSB) repair mechanisms in quiescent and proliferating cells and major proteins participating in them. RAD52 as a potential target for synthetic lethality-based therapy has been marked in red. poly(ADP-ribose) polymerase 1 inhibitors (PARP1) and Polθ—promising partners for dual synthetic lethality have been marked in green.